Distributor inventory | Vial
Insulin (Human) 50% Isophane (NPH) + 50% Regular (Soluble) Injection, 40 IU/mL
Management of diabetes mellitus (Type 1 and Type 2) requiring insulin; control of blood glucose levels when a premixed insulin regimen is prescribed
This is a premixed human insulin containing short-acting regular insulin and intermediate-acting NPH insulin. Regular insulin provides meal-time glucose control, while NPH insulin provides longer basal control. Together they help lower blood sugar by increasing glucose uptake in muscle/fat and reducing hepatic glucose output.
For subcutaneous injection only as advised by the doctor (commonly 1–2 times daily, usually 30 minutes before meals). Roll the vial gently to resuspend (do not shake vigorously). Use insulin syringe suitable for U-40 strength; rotate injection sites (abdomen, thigh, upper arm). Do not use if clumped/particles or if solution appears abnormal.
Common side effects of XSULIN 50/50 VIAL 40IU may include:
Risk of severe hypoglycaemia—monitor blood glucose regularly and carry fast-acting glucose. Dose adjustments may be needed with changes in diet, exercise, illness, renal/hepatic impairment, or when switching insulin brands/strengths. Do not inject intravenously; not for insulin pumps. Use correct strength syringes (U-40) to avoid dosing errors. Seek urgent help for severe allergy (wheezing, swelling, generalized rash) or recurrent hypoglycaemia.
